Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration

Brain Research
Deepinder KaurJulie K Andersen

Abstract

Ferritin elevation has been reported by some laboratories to occur within the substantia nigra (SN), the area of the brain affected in Parkinson's disease (PD), but whether such an increase could be causatively involved in neurodegeneration associated with the disorder is unknown. Here, we report that chronic ferritin elevation in midbrain dopamine-containing neurons results in a progressive age-related neurodegeneration of these cells. This provides strong evidence that chronic ferritin overload could be directly involved in age-related neurodegeneration such as occurs in Parkinson's and other related diseases.

References

Dec 1, 1989·Biochemical Pharmacology·H P Monteiro, C C Winterbourn
Feb 1, 1989·Journal of Neurochemistry·P RiedererM B Youdim
Dec 1, 1994·Annals of Neurology·V M MannA H Schapira
Dec 1, 1995·Journal of the Neurological Sciences·E KienzlR F Jameson
May 29, 1998·Journal of Neurochemistry·K L DoubleM Gerlach
Jan 28, 2003·Blood Cells, Molecules & Diseases·Douglas E CromptonJohn Burn
Apr 24, 2004·Annals of the New York Academy of Sciences·Sophia R SmithTracey A Rouault
Apr 24, 2004·Annals of the New York Academy of Sciences·George BartzokisJeffrey L Cummings
Mar 2, 2005·Best Practice & Research. Clinical Haematology·Sonia LeviPaolo Arosio
Apr 20, 2005·Journal of Neuropathology and Experimental Neurology·Michelangelo MancusoJames M Powers
Apr 29, 2005·Journal of Neurochemistry·Alison L McCormackDonato A Di Monte

❮ Previous
Next ❯

Citations

Apr 20, 2010·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Bistra IordanovaEric T Ahrens
Mar 11, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George BartzokisJames R Connor
Apr 2, 2008·Antioxidants & Redox Signaling·Cecilia Hidalgo, Paulina Donoso
Mar 11, 2008·Antioxidants & Redox Signaling·Elizabeth L MacKenzieYoshiaki Tsuji
Mar 18, 2009·Tissue Engineering. Part C, Methods·Jun LiuAnthony W S Chan
Jan 9, 2014·ASN Neuro·Kelsey J WeigelSteven M Levine
Apr 27, 2012·Journal of Biomedicine & Biotechnology·Yupeng FengLi Li
Aug 26, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jin-Yul LeeGuohua Xi
Oct 22, 2008·Biochimica Et Biophysica Acta·Paolo ArosioPatrizia Cavadini
Jan 6, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Batya CohenMichal Neeman
Mar 15, 2011·The European Journal of Neuroscience·Sebastien Couillard-Despres, Ludwig Aigner
Jan 21, 2010·Journal of Neurochemistry·Donna W Lee, Julie K Andersen
Mar 30, 2010·Journal of Neurochemistry·Daniel Johnstone, Elizabeth A Milward
Mar 19, 2014·Drug Discovery Today·Yiju ChenAnthony W S Chan
Feb 18, 2015·PloS One·Sara CapocciaFrancesca Cirulli
Jul 15, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Anna V Naumova, Greetje Vande Velde
Jan 17, 2013·Metallomics : Integrated Biometal Science·Dominic J HareDavid I Finkelstein
Sep 4, 2020·Experimental Biology and Medicine·Santosh R D'Mello, Mark C Kindy
Jul 5, 2017·Cellular and Molecular Life Sciences : CMLS·Piotr JurgielewiczOmer Aras

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.